Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Michael A. Mcdevitt · SciRah

Researcher profile · Semantic Scholar

Michael A. Mcdevitt

Share profile

Michael A. Mcdevitt — researcher profile on SciRah

h-index: 52
Works: 156
Citations: 9,141

Most-cited papers

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
A. Jankowska, H. Makishima, R. Tiu, H. Szpurka +12 more
2011Blood350 citations Open access
Semantic Scholar
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Shannon R. McCurdy, J. Kanakry, M. Showel, Hua-Ling Tsai +23 more
2015Blood296 citations Open access
Semantic Scholar
Somatic SETBP1 mutations in myeloid malignancies
H. Makishima, K. Yoshida, N. Nguyen, B. Przychodzen +26 more
2013Nature Genetics259 citations Open access
Semantic Scholar
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.
Christine M. O'Keefe, Michael A. Mcdevitt, J. Maciejewski
2010Blood231 citations Open access
Semantic Scholar
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.
Yvette L. Kasamon, J. Bolaños-Meade, G. Prince, Hua-Ling Tsai +22 more
2015Journal of Clinical Oncology225 citations Open access
Semantic Scholar
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
H. Makishima, Heather Cazzolli, H. Szpurka, A. Dunbar +11 more
2009Journal of Clinical Oncology219 citations Open access
Semantic Scholar
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
R. Tiu, Lukasz P. Gondek, C. O'Keefe, P. Elson +10 more
2011Blood210 citations Open access
Semantic Scholar
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
H. Makishima, A. Jankowska, R. Tiu, H. Szpurka +11 more
2010Leukemia201 citations Open access
Semantic Scholar
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
G. Baerlocher, Elisabeth Oppliger Leibundgut, O. Ottmann, G. Spitzer +7 more
2015New England Journal of Medicine197 citations Open access
Semantic Scholar
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.
C. Kanakry, Hua-Ling Tsai, J. Bolaños-Meade, B. Smith +20 more
2014Blood186 citations Open access
Semantic Scholar
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
H. Makishima, A. Jankowska, Michael A. Mcdevitt, C. O'Keefe +12 more
2011Blood160 citations Open access
Semantic Scholar
Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: Outcomes from 133 consecutive newly-diagnosed patients from a single institution
A. Dezern, A. Sung, S.-H. Kim, B. D. Smith +7 more
2011Biology of Blood and Marrow Transplantation150 citations Open access
Semantic Scholar
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
S. Khan, A. Jankowska, R. Mahfouz, A. Dunbar +15 more
2013Leukemia137 citations
Semantic Scholar
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
A. Jerez, Y. Sugimoto, H. Makishima, A. Verma +18 more
2012Blood121 citations Open access
Semantic Scholar
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
R. Tiu, Lukasz P. Gondek, C. O'Keefe, J. Huh +8 more
2009Journal of Clinical Oncology117 citations Open access
Semantic Scholar
Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
J. Karp, B. Thomas, J. Greer, C. Sorge +18 more
2012Clinical Cancer Research116 citations Open access
Semantic Scholar
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
A. Jerez, Lukasz P. Gondek, A. Jankowska, H. Makishima +9 more
2012Journal of Clinical Oncology116 citations Open access
Semantic Scholar
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias
K. Pratz, Eunpi Cho, M. Levis, J. Karp +9 more
2010Leukemia114 citations Open access
Semantic Scholar
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes
B. Stein, D. Williams, C. O'Keefe, O. Rogers +6 more
2011Haematologica104 citations Open access
Semantic Scholar
Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
Sara Abu Kar, A. Jankowska, H. Makishima, V. Visconte +14 more
2013Haematologica98 citations Open access
Semantic Scholar
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
E. Griffiths, S. D. Gore, C. Hooker, Michael A. Mcdevitt +6 more
2010Leukemia and Lymphoma90 citations Open access
Semantic Scholar
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.
J. Karp, B. D. Smith, Linda Resar, J. Greer +15 more
2011Blood78 citations Open access
Semantic Scholar
CLINICAL ACTIVITY OF SEQUENTIAL FLAVOPIRIDOL, CYTOSINE ARABINOSIDE, AND MITOXANTRONE FOR ADULTS WITH NEWLY DIAGNOSED, POOR RISK ACUTE MYELOGENOUS LEUKEMIA
J. Karp, A. Blackford, B. D. Smith, Katrina Alino +10 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis77 citations Open access
Semantic Scholar
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysis
J. Huh, R. Tiu, Lukasz P. Gondek, C. O'Keefe +8 more
2010Genes, Chromosomes and Cancer76 citations
Semantic Scholar
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.
Youl-Nam Lee, Stephanie Brandal, P. Noel, Erik A. Wentzel +6 more
2011Blood73 citations Open access
Semantic Scholar
Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients
C. Cheadle, Alan E. Berger, S. Mathai, D. Grigoryev +13 more
2011PLoS ONE68 citations Open access
Semantic Scholar
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
J. Karp, Elizabeth Garrett-Mayer, E. Estey, M. Rudek +16 more
2012Haematologica64 citations Open access
Semantic Scholar
A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia
I. Gojo, J. H. Beumer, K. Pratz, Michael A. Mcdevitt +21 more
2016Clinical Cancer Research62 citations Open access
Semantic Scholar
Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies
I. Gómez-Seguí, H. Makishima, Andrés Jerez, K. Yoshida +12 more
2013Leukemia62 citations Open access
Semantic Scholar
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms
Sangeeta Nischal, Sanchari Bhattacharyya, M. Christopeit, Yiting Yu +14 more
2012Cancer Research61 citations Open access
Semantic Scholar
5-Azacytidine as Salvage Treatment in Relapsed Myeloid Tumors after Allogeneic Bone Marrow Transplantation
J. Bolaños-Meade, B. Smith, S. D. Gore, Michael A. Mcdevitt +3 more
2010Biology of Blood and Marrow Transplantation58 citations Open access
Semantic Scholar
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms
J. Zeidner, J. Karp, A. Blackford, B. D. Smith +8 more
2014Haematologica56 citations Open access
Semantic Scholar
Recurrent genetic defects on chromosome 5q in myeloid neoplasms
N. Hosono, H. Makishima, R. Mahfouz, B. Przychodzen +19 more
2016OncoTarget48 citations Open access
Semantic Scholar
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
E. Griffiths, S. Gore, C. Hooker, Helai P. Mohammad +5 more
2010Epigenetics47 citations Open access
Semantic Scholar
Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
Michael A. Mcdevitt
2012Seminars in Oncology45 citations Open access
Semantic Scholar
A Phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms and chronic myelomonocytic leukemia
K. Pratz, M. Rudek, I. Gojo, M. Litzow +16 more
2016Clinical Cancer Research39 citations Open access
Semantic Scholar
Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors
Toyoko Hiroi, Clayton B. Deming, Haige Zhao, B. Hansen +4 more
2009Arteriosclerosis, Thrombosis and Vascular Biology39 citations Open access
Semantic Scholar
Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling
Hrishikesh M. Mehta, Taly Glaubach, A. Long, Hannah Lu +6 more
2013Leukemia28 citations Open access
Semantic Scholar
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.
J. Karp, Tatiana I. Vener, M. Raponi, Ellen K. Ritchie +19 more
2012Blood27 citations Open access
Semantic Scholar
Poly(ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
K. Pratz, Brian D. Koh, Anand G. Patel, K. Flatten +9 more
2016Clinical Cancer Research25 citations Open access
Semantic Scholar
Lenalidomide-induced acute interstitial nephritis.
E. Lipson, C. Huff, Danniele Holanda, Michael A. Mcdevitt +1 more
2010The Oncologist23 citations Open access
Semantic Scholar
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells
J. Pu, R. Hu, G. Mukhina, H. Carraway +2 more
2012Haematologica22 citations Open access
Semantic Scholar
BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
W. Poh, Robert L. Dilley, A. Moliterno, J. Maciejewski +3 more
2019Clinical Cancer Research18 citations
Semantic Scholar
PU.1 Positively Regulates GATA-1 Expression in Mast Cells
C. Takemoto, Stephanie Brandal, A. Jegga, Youl-Nam Lee +4 more
2010Journal of Immunology18 citations Open access
Semantic Scholar
Burst-Forming Unit-Erythroid Assays (BFU-E) To Distinguish Cellular Bone Marrow Failure Disorders
A. Dezern, J. Pu, Michael A. Mcdevitt, Richard J. Jones +1 more
2013Experimental Hematology15 citations Open access
Semantic Scholar
Large-vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia.
J. Park, A. Gelber, G. Zheng, Michael A. Mcdevitt +2 more
2011Journal of Clinical Oncology14 citations
Semantic Scholar
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat
E. Leibundgut, M. Haubitz, B. Burington, O. Ottmann +6 more
2020Haematologica13 citations Open access
Semantic Scholar
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
K. Norsworthy, A. Dezern, Hua-Ling Tsai, Wesley Hand +15 more
2017Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis12 citations Open access
Semantic Scholar
Poly (ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro
Robert L. Dilley, W. Poh, D. Gladstone, J. Herman +4 more
2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis11 citations Open access
Semantic Scholar
CBL , CBLB , TET 2 , ASXL 1 , and IDH 1 / 2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
H. Makishima, A. Jankowska, Michael A. Mcdevitt, C. O'Keefe +13 more
201111 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Maciejewski×18
Invite
J. Maciejewski — researcher profile on SciRah
H. Makishima×14
Invite
H. Makishima — researcher profile on SciRah
K. Pratz×13
Invite
K. Pratz — researcher profile on SciRah
M. Sekeres×12
Invite
M. Sekeres — researcher profile on SciRah

×11

Invite

C. O'Keefe — researcher profile on SciRah

H. Carraway×11

Invite

H. Carraway — researcher profile on SciRah

B. D. Smith×10

Invite

B. D. Smith — researcher profile on SciRah

Invite

M. Levis — researcher profile on SciRah

B. Przychodzen×10

Invite

B. Przychodzen — researcher profile on SciRah

Invite

R. Tiu — researcher profile on SciRah

D. Gladstone×9

Invite

D. Gladstone — researcher profile on SciRah

Invite

J. Karp — researcher profile on SciRah